Science Explorer Back to mapMap
Discussion
Company · Belfast · United Kingdom

Celerion (United Kingdom)

celerion.comROR OpenAlex
Research works
12
▼ 52% vs 2018-21
Citations
174
14.1 per fractional work
Top-10% rate
16.9%
all institutions 10.0%
Open access
52%
world 40%
International
50%
world 18%
Celerion (United Kingdom)

Not ranked overall: Celerion (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Celerion (United Kingdom) work in?

In all years, 51% of research at Celerion (United Kingdom) is in Health Sciences, 21% in Life Sciences. Its largest fields are Medicine (51%), Immunology and Microbiology (11%), Economics, Econometrics and Finance (10%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 51.3% of its workMedicine: 6 fractional works · 50.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 10.5% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 8.1% of its workPhysiology: 1 fractional works · 6.8% of its workOncology: 1 fractional works · 5.6% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 3.6% of its workPharmacology: 0 fractional works · 3.6% of its workEmergency Medicine: 0 fractional works · 2.7% of its workObstetrics and Gynecology: 0 fractional works · 2.7% of its workEpidemiology: 0 fractional works · 1.8% of its workReproductive Medicine: 0 fractional works · 1.4% of its workImmunology and Allergy: 0 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workSurgery: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.5% of its workHematology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 0 fractional works · 0.8% of its workEmergency Medical Services: 0 fractional works · 0.8% of its workLife Sciences: 3 fractional works · 21.0% of its workImmunology and Microbiology: 1 fractional works · 10.9% of its workImmunology: 1 fractional works · 10.9% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 5.8% of its workMolecular Biology: 1 fractional works · 4.7% of its workPhysiology: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 4.3% of its workPharmacology: 0 fractional works · 3.8% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workPhysical Sciences: 2 fractional works · 14.9% of its workEngineering: 1 fractional works · 6.9% of its workElectrical and Electronic Engineering: 1 fractional works · 5.4% of its workBiomedical Engineering: 0 fractional works · 1.5% of its workChemistry: 0 fractional works · 2.9% of its workAnalytical Chemistry: 0 fractional works · 2.0% of its workOrganic Chemistry: 0 fractional works · 0.9% of its workComputer Science: 0 fractional works · 2.3% of its workComputer Networks and Communications: 0 fractional works · 1.4% of its workComputational Theory and Mathematics: 0 fractional works · 0.9% of its workEnvironmental Science: 0 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.9% of its workEarth and Planetary Sciences: 0 fractional works · 0.6% of its workOceanography: 0 fractional works · 0.6% of its workEnergy: 0 fractional works · 0.6% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.6% of its workMathematics: 0 fractional works · 0.6% of its workStatistics and Probability: 0 fractional works · 0.6% of its workSocial Sciences: 2 fractional works · 12.8% of its workEconomics, Econometrics and Finance: 1 fractional works · 10.2% of its workEconomics and Econometrics: 1 fractional works · 10.2% of its workSocial Sciences: 0 fractional works · 1.8% of its workDemography: 0 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.9% of its workBusiness, Management and Accounting: 0 fractional works · 0.9% of its workMarketing: 0 fractional works · 0.9% of its workALL ITS WORKCelerion (UnitedKingdom)12fractional works, all years
Life Sciences21%Physical Sciences15%Health Sciences51%Social Sciences13%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine650.5%
    2. Health Professions00.8%
    1. Immunology and Microbiology110.9%
    2. Biochemistry, Genetics and Molecular Biology15.8%
    3. Pharmacology, Toxicology and Pharmaceutics14.3%
    1. Engineering16.9%
    2. Chemistry02.9%
    3. Computer Science02.3%
    4. Environmental Science00.9%
    5. Earth and Planetary Sciences00.6%
    6. Energy00.6%
    7. Mathematics00.6%
    1. Economics, Econometrics and Finance110.2%
    2. Social Sciences01.8%
    3. Business, Management and Accounting00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.74× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.17× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 42.61× its world share, 0 worksPharmacology, Toxico…Chemistry: 7.32× its world share, 0 worksChemistryComputer Science: 0.45× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringMedicine: 3.17× its world share, 2 worksMedicineEconomics, Econometrics and Finance: 1.65× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 42.6×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics42.61×0 works
  2. Chemistry7.32×0 works
  3. Medicine3.17×2 works
  4. Economics, Econometrics and Finance1.65×0 works
  5. Immunology and Microbiology1.17×0 works
  6. Biochemistry, Genetics and Molecular Biology0.74×0 works
  7. Computer Science0.45×0 works
  8. Engineering0.03×0 works

What are the most cited papers from Celerion (United Kingdom)?

The most cited paper from Celerion (United Kingdom) is "Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects" (Nathan Gale, Mike McEwan, Alison C. Eldridge et al., 2018), with 95 citations. Next come "Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD" (81) and "Nicotine pharmacokinetics of electronic cigarettes: A review of the literature" (58).

Most cited papers
#PaperReleasedCitations
1 Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects Nathan Gale, Mike McEwan, Alison C. Eldridge et al. · Nicotine & Tobacco Research Open access 17 May 2018 95
2 Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD Dave Singh, Kai Michael Beeh, Brendan Colgan et al. · Respiratory Research Open access 9 Aug 2019 81
3 Nicotine pharmacokinetics of electronic cigarettes: A review of the literature Ian M. Fearon, Alison C. Eldridge, Nathan Gale et al. · Regulatory Toxicology and Pharmacology 8 Sep 2018 58
4 Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis Mirco Govoni, Michele Bassi, Stefano Vezzoli et al. · Respiratory Research Open access 20 Mar 2020 32
5 8th GCC: Consolidated Feedback to US FDA on The 2013 Draft FDA Guidance on Bioanalytical Method Validation Joseph F. Bower et al. · Bioanalysis Nov 2014 32
All 26 most cited papers, with filters and sorting

Which research topics does Celerion (United Kingdom) publish most on?

By volume in 2022-now: Pharmaceutical studies and practices, Drug-Induced Adverse Reactions, Pharmacological Effects of Natural Compounds and Intramuscular injections and effects.

Pharmaceutical studies and practices: 0 fractional worksDrug-Induced Adverse Reactions: 0 fractional worksPharmacological Effects …0Pharmacological Effects of Natural Compounds: 0 fractional worksIntramuscular injections…0Intramuscular injections and effects: 0 fractional worksAnalytical Methods in Ph…0Analytical Methods in Pharmaceuticals: 0 fractional worksPharmacogenetics and Dru…0Pharmacogenetics and Drug Metabolism: 0 fractional worksAdenosine and Purinergic Signaling: 0 fractional worksDrug Transport and Resistance Mechanisms: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksComputational Drug Discovery Methods: 0 fractional works
Pediatrics, Perinatology and Child HealthPharmacologyEmergency MedicineAnalytical Chemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
  2. 2 Drug-Induced Adverse Reactions Pharmacology 0 works
  3. 3 Pharmacological Effects of Natural Compounds Pharmacology 0 works
  4. 4 Intramuscular injections and effects Emergency Medicine 0 works
  5. 5 Analytical Methods in Pharmaceuticals Analytical Chemistry 0 works
  6. 6 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
  7. 7 Adenosine and Purinergic Signaling Physiology 0 works
  8. 8 Drug Transport and Resistance Mechanisms Oncology 0 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.2%not open47.8%

World: 40% of research is openly available.

with international co-authors50.1%domestic only49.9%

World: 18% is written across borders.

How has Celerion (United Kingdom)'s research output changed?

Output in 2022-2025 was 52% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Celerion (United Kingdom) as a percentage of every work published that year, 0.000016% in 2024.

still counting0.000020%0.000040%0.000060%Celerion (United Kingdom)0.0000085% in 202520102020

Fractional works of Celerion (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Belfast

All research institutions in Belfast

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Celerion (United Kingdom). Posts are plain text and can be reported.